Schedule 13G ownership disclosure

ASCENDIS PHARMA A/S

Security class unavailable · CUSIP: 04351P101

Event date: 2022-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,158,168
Percent of class
5.5400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-23-000558
Form type
SC 13G
Filer
Ascendis Pharma A/S
CIK
CIK 1612042
Filed
Feb 02, 2023
Reporting period
Dec 30, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub